One of the other key valuation multiples is PEG (price-to-earnings-to-growth) ratio, which is a growth-adjusted valuation multiple. It can be used to compare the valuation of companies with different growth profiles in different industries.
On September 27, Sanofi had a 12-month forward PEG ratio of 2.1x, while peers Pfizer (PFE), Novartis (NVS), and Amgen (AMGN) had forward PEG ratios of 1.8x, 2.2x, and 2.1x, respectively. Their forward PE ratios were 14.2x, 15.8x, and 14.4x, respectively.
Be sure to check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data, as well as dividend information. Take a look!